pharmacotherapeutics Flashcards
alkylating agents (cyclophosphamide, cisplatin) MOA
bind to DNA and prevent proper DNA replication.
alkylating agents (cyclophosphamide, cisplatin) major side effects
BONE MARROW SUPPRESSION, Nausea/vomiting/diarrhea, alopecia, neuropathy
antimetabolites (methotrexate, fluorouracil) MOA
interferes w DNA and RNA growth by substituting for the normal bldg blocks of DNA and RNA (folate antagonist)
antimetabolites (methotrexate, fluorouracil) major side effects
NEUROTOXICITY, nausea/vomiting/diarrhea, alopecia, bone marrow suppression
aromatase inhibitors (anastrozole) MOA
lowers estrogen levels by stopping an enzyme in fat tissue from changing other hormones into estrogen (BREAST CANCER)
aromatase inhibitors (anastrozole) major side effects
fractures, osteoporosis, thromboembolism (MI, stroke), hot flashes, pain, arthralgias, asthenia, N/V, headache
antimicrotubules (vinka alkyloids, cincristine, paclitaxel) MOA
blocks cell growth by stopping mitosis
antimicrotubules (vinka alkyloids, cincristine, paclitaxel) major side effects
peripheral neuropathy, neutropenia
enzyme inhibitors (irinotecan, imatinib) MOA
inhibits enzymes
enzyme inhibitors (irinotecan, imatinib) major side effects
cholinergic toxicity, alopecia, diarrhea
targeted therapies (imatinib) MOA
imatinib inhibits tyrosine kinase to block proliferation and induce apoptosis
targeted therapies (imatinib) major side effects
fluid retention, edema, hepatotoxicity, thrombocytopenia or neutropenia, n/v
gene therapies clinical use
experimental! systemic or local tx of malignancies; often use viral vectors for transfer of genes, also methods to stop angiogenesis; currently best used in combo with chemo, adjuvant therapy
gene therapies major side effects
often less toxic than chemo because delivered local or with specific target; has not shown to be a superior tx, however; still too new
anthracyclines (doxorubicin) clinical use
cytotoxic. messes w the DNA